spacer
spacer

PDBsum entry 4csv

Go to PDB code: 
protein ligands links
Transferase PDB id
4csv

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
244 a.a.
Ligands
STI
Waters ×56
PDB id:
4csv
Name: Transferase
Title: Tyrosine kinase as - a common ancestor of src and abl bound to gleevec
Structure: Src-abl tyrosine kinase ancestor. Chain: a. Fragment: kinase domain. Engineered: yes
Source: Synthetic construct. Organism_taxid: 32630. Expressed in: escherichia coli. Expression_system_taxid: 469008.
Resolution:
2.05Å     R-factor:   0.190     R-free:   0.242
Authors: S.Kutter,C.Wilson,L.Cruz,R.V.Agafonov,M.S.Hoemberger,A.Zorba,D.Kern
Key ref: C.Wilson et al. (2015). Kinase dynamics. Using ancient protein kinases to unravel a modern cancer drug's mechanism. Science, 347, 882-886. PubMed id: 25700521 DOI: 10.1126/science.aaa1823
Date:
10-Mar-14     Release date:   04-Mar-15    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
No UniProt id for this chain
Struc: 244 a.a.
Key:    Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.2.7.10.2  - non-specific protein-tyrosine kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
L-tyrosyl-[protein]
+ ATP
= O-phospho-L-tyrosyl-[protein]
+ ADP
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
DOI no: 10.1126/science.aaa1823 Science 347:882-886 (2015)
PubMed id: 25700521  
 
 
Kinase dynamics. Using ancient protein kinases to unravel a modern cancer drug's mechanism.
C.Wilson, R.V.Agafonov, M.Hoemberger, S.Kutter, A.Zorba, J.Halpin, V.Buosi, R.Otten, D.Waterman, D.L.Theobald, D.Kern.
 
  ABSTRACT  
 
Macromolecular function is rooted in energy landscapes, where sequence determines not a single structure but an ensemble of conformations. Hence, evolution modifies a protein's function by altering its energy landscape. Here, we recreate the evolutionary pathway between two modern human oncogenes, Src and Abl, by reconstructing their common ancestors. Our evolutionary reconstruction combined with x-ray structures of the common ancestor and pre-steady-state kinetics reveals a detailed atomistic mechanism for selectivity of the successful cancer drug Gleevec. Gleevec affinity is gained during the evolutionary trajectory toward Abl and lost toward Src, primarily by shifting an induced-fit equilibrium that is also disrupted in the clinical T315I resistance mutation. This work reveals the mechanism of Gleevec specificity while offering insights into how energy landscapes evolve.
 

 

spacer

spacer